Mulakan
ReutersReuters

Novocure To Present Data From Phase 3 Panova-3 Trial Of Tumor Treating Fields In Pancreatic Cancer At Esmo Gastrointestinal Cancers Congress 2025

RefinitivBacaan kurang dari 1 minit
NVCR

Novocure Ltd NVCR:

  • NOVOCURE TO PRESENT FINAL SECONDARY ENDPOINT DATA FROM THE PHASE 3 PANOVA-3 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) IN PANCREATIC CANCER AT THE ESMO GASTROINTESTINAL CANCERS CONGRESS 2025

EropahReutersSaham UK
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini

Lebih berita dari Reuters